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1. Introduction 
In 1968, on the basis of the three-dimensional 
model, the unstable hemoglobins have been discussed 
by Perutz and Lehmann [ 11. They demonstrated that 
the instability of the protein was a consequence of 
structural modifications located on some definite parts 
of the molecule among which are in the vicinity of 
the heme group. 
We have proposed recently a tentative systematic 
classification of hemoglobins mutated in the heme 
pocket according to the three-dimensional position of 
the abnormality [2]. The loss of heme, which is know 
known to be a major sign, was found in significant 
,amounts only in substitutions located on helix F and 
‘segment FG. 
In this paper, a new unstable hemoglobin belonging 
to this group is described : Hb Djelfa, in which the 
/3 98 (FG 5) valine is replaced by an alanine. 
and Huehns [4]. At 4°C after an 18 h reaction, the 
abnormal chain precipitated, while the normal ones 
remained soluble. 
The heme was then removed from the hemoglobin 
by the acid-acetone method. The p chain was purified 
from a slight amount of co-precipitated cy chain by 
chromatography on CM cellulose according to Clegg 
et al. [5] and amino-ethylated [6]. 
After tryptic digestion an analytical peptide map 
was made on cellulose thin layer as previously describ- 
ed [7]. For further studies, the peptides were fraction- 
ated by ion-exchange chromatography on Beckman 
PA 35 resin according to Jones [8]. Purification of the 
abnormal peptide was done with the same system, 
using AG 50 W-X2 resin. 
After hydrolysis by HCl the aminoacid composi- 
tion of the peptide was determined on a Beckman 
120 C aminoacid analyzer. 
3. Results and discussion 
2. Material and methods 
Blood was collected on heparin and hemolysate 
prepared by routine procedures. 
Electrophoresis was done on cellulose acetate in 
Tris EDTA-borate buffer, pH 8.6. The stability was 
studied by the isopropanol method [3]. 
The abnormal component was selectively isolated 
by p-mercuribenzoate (PMB) using a ratio of 8 PMB/ 
tetramer Hb according to the technique of Rosemeyer 
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3.1. Electrophoretic studies and stability test 
The electrophoresis of the lysate, at alkaline pH, 
revealed, in addition to normal hemoglobin, approx. 
5% of a minor component migrating slightly more 
anodically than Hb AZ. There was no fetal hemoglobin 
and the level of Hb AZ was normal. This minor band 
was not modified by potassium cyanide, but disappear- 
ed after addition of an excess of hemin, indicating 
that it was a partially deheminized component. 
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This electrophoretic pattern was very similar to 
that observed with Hb KSln 191. 
In the presence of 17% isopropanol a clear preci- 
pitation was observed within 20 min. 
3.2. Structural studies 
Alkylation by PMB led to precipitation of about 
15% of the total hemoglobin. It was proved, by chain 
separation in urea, to be 90% pure 0 chain, with 
normal chromatographic behaviour. 
The finger-print of the tryptic digest and the elution 
pattern on ion-exchange chromatography were both 
normal. 
To avoid a long and tedious systematic study of all 
the peptides, we referred to the results of our tentative 
classification [2]. The loss of heme was the major 
feature of one group described, this group (table 1) 
including Hb K61n, the most common unstable hemo- 
globin and other variants all characterized by a struc- 
tural abnormality located on helix F and segment FG. 
The first peptides purified by ion-exchange chromato- 
graphy were therefore PT 10 and /3T 11, which corre- 
spond to this part of the molecule. In the aminoacid 
analysis of peptide PT 11, instead of one residue of 
valine, one residue of alanine was found (table 2), the 
sequence of peptide /3T 11 being then: 
Leu-His-A&-Asp-Pro-Glu-Asp-Phe-Arg 
96 98 100 104 
instead of: 
L.eu- Hi-Val-Asp-Pro-Glu-Asp-Phe-Arg 
96 104 
Table 1 
Abnormal hemoglobins characterized by a loss of heme 
Abnormal Substituted 
hemoglobin Residue Ref. 
_____ 
Hb Tours F3 p 87 Thr --f 0 [l 1 
Hb Santa Ana F4 P88Leu -*Pro 1121 
Hb Sabine F7 p91 Leu + Pro [13] 
Hb St Etiennea F8 p 92 His + Gin [14] 
Hb Gun Hilla F7-FG2 p 91-95 -+ 0 [151 
Hb Kaln FG5 p 98 Val + Met [16] 
Hb Nottingham FG5 p 98 Val + Gly [17] 
aThese two variants are natural semi-hemoglobins unable to 
bind the heme. 
Table 2 
Amino acid composition of peptide p T II 
Residues found Composition of 
normal p T II 
Histidine 
Arginine 
Aspartic acid 
Glutamic acid 
Proline 
Alanine 
Valine 
Leucine 
Phenylalanine 
- 
1.0 1 
0.9 1 
2.1 2 
1.0 1 
1.0 1 
1.0 0 
E 1 
G i 
0.9 1 
Hb Djelfa is the third variant of a substitution located 
at position FG 5, the two others being Hb K61n and 
Hb Nottingham. 
Preliminary studies give evidence of functional 
abnormalities almost identical to those described for 
Hb Kijln [lo] : in intact cells the oxygen affinity is 
increased and the curve is biphasic. This new variant 
demonstrates once more that the proximal side of the 
heme plane is fundamental in the heme-globin 
binding. 
From the methodological point of view, it is inter- 
esting to notice that an indication of the altered part 
of the molecule can be given by various approaches. 
The most common is a charge or polarity difference 
of a given peptide, but other properties, like the heme 
loss, can be useful tools. 
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